(Tyr5.12,Lys7)-Polyphemusin II
147658-54-6
|
Polyphemusin II-Derived Peptide
229030-20-0
|
polyphemusin II, Tyr(5,12)-Lys(7)-
142960-16-5
|
polyphemusin I
125139-67-5
|
cobalt(II)(glycinate)(1+)
100293-84-3
|
Urotensin II-Related Peptide (human, mouse, rat) trifluoroacetate salt
342878-90-4
|
indium(ii) chloride
13465-11-7
|
lead(ii) tartrate
815-84-9
|
lead(II) carbonate
790616-79-4
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
N-(4-bromophenyl)-4,4-dimethyl-3,8-dioxo-1-sulfanyl-3,4,7,8-tetrahydro-6H-pyrazolo[1,2-a][1,2,4]triazine-6-carboxamide
956257-16-2
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
2-(1-(3,4-dimethylphenyl)-4-isopropyl-7-oxo-1H-pyrazolo[3,4-d]pyridazin-6(7H)-yl)-N-(3-methoxyphenyl)acetamide
946379-49-3
|
1-(3-Methoxyphenyl)pent-4-en-1-ol
125997-10-6
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
